Werewolf Therapeutics, Inc. (HOWL)
0.9844
0.00 (0.00%)
USD |
NASDAQ |
Sep 11, 10:49
Werewolf Therapeutics Market Cap : 47.84M for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 10, 2026 | 48.04M |
| September 09, 2026 | 46.90M |
| September 08, 2026 | 47.63M |
| September 04, 2026 | 46.96M |
| September 03, 2026 | 45.87M |
| September 02, 2026 | 48.52M |
| September 01, 2026 | 46.53M |
| August 31, 2026 | 45.73M |
| August 28, 2026 | 45.84M |
| August 27, 2026 | 47.18M |
| August 26, 2026 | 48.05M |
| August 25, 2026 | 43.25M |
| August 24, 2026 | 42.93M |
| August 21, 2026 | 42.45M |
| August 20, 2026 | 20.96M |
| August 19, 2026 | 19.89M |
| August 18, 2026 | 19.89M |
| August 17, 2026 | 19.71M |
| August 14, 2026 | 19.67M |
| August 13, 2026 | 18.76M |
| August 12, 2026 | 18.56M |
| August 11, 2026 | 18.65M |
| August 10, 2026 | 18.56M |
| August 07, 2026 | 19.30M |
| August 06, 2026 | 19.58M |
| Date | Value |
|---|---|
| August 05, 2026 | 19.54M |
| August 04, 2026 | 20.15M |
| August 03, 2026 | 17.86M |
| July 31, 2026 | 17.16M |
| July 30, 2026 | 24.32M |
| July 29, 2026 | 22.36M |
| July 28, 2026 | 21.84M |
| July 27, 2026 | 22.03M |
| July 24, 2026 | 20.75M |
| July 23, 2026 | 17.50M |
| July 22, 2026 | 17.75M |
| July 21, 2026 | 17.64M |
| July 20, 2026 | 17.88M |
| July 17, 2026 | 17.88M |
| July 16, 2026 | 17.88M |
| July 15, 2026 | 16.50M |
| July 14, 2026 | 16.72M |
| July 13, 2026 | 16.60M |
| July 10, 2026 | 19.58M |
| July 09, 2026 | 18.39M |
| July 08, 2026 | 17.49M |
| July 07, 2026 | 16.72M |
| July 06, 2026 | 15.55M |
| July 02, 2026 | 16.54M |
| July 01, 2026 | 17.15M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 12.00B |
| Oncolytics Biotech, Inc. | 93.54M |
| Sangamo Therapeutics, Inc. | 64.38M |
| Sarepta Therapeutics, Inc. | 2.176B |
| Anixa Biosciences, Inc. | 97.53M |
Market Cap Related Metrics
| PS Ratio | 2.253 |
| Price to Book Value | 2.936 |
| Price | 0.9844 |
| Earnings Yield | -75.03% |